Ursula Ehmer

ORCID: 0000-0002-0441-1953

Also affiliated with TUM Klinikum, University Medical Center, Deutsches Konsortium für Translationale Krebsforschung, Technical University of Munich

MedicinePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab”.

Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab

JHEP Reports(2024)10.1016/j.jhepr.2024.101295

N/A

0DataRank · unranked

9 citations

Philipp Mildenberger, Jennifer Gile, Fabian Jost‐Brinkmann, Bernhard Scheiner, Catherine Leyh +54 more

PARP-1 selectively impairs KRAS -driven phenotypic and molecular features in intrahepatic cholangiocarcinoma

Gut(2024)10.1136/gutjnl-2023-331237

N/A

0DataRank · unranked

10 citations

Darko Castven, Diana Becker, Stojan R. Stojković, Jovana Castven, Carolin Zimpel +22 more